5 Stocks Held by Vanguard with P/E Ratio Lower Than the Industry Average

Synopsis: Five Vanguard-held stocks trade below industry valuation multiples while delivering strong capital efficiency, highlighting attractive opportunities backed by institutional confidence.

The Vanguard Fund is one of the world’s largest global investment managers, known for its disciplined, long-term and largely passive investment strategy. As per the latest exchange filings, it publicly holds 48 Indian stocks with a combined value of over ₹67,434.3 crore, reflecting substantial institutional exposure.

For investors, tracking these holdings can offer meaningful cues. When a global institution allocates thousands of crores to specific companies, it often indicates confidence in governance quality, earnings visibility, and scalability. Studying such stocks may help you identify fundamentally strong businesses backed by credible, long-term capital. Here are the 5 stocks held by Vanguard trading at an attractive price

Suzlon Energy Ltd

Suzlon is one of the leading global renewable energy solutions providers. It is a vertically integrated WTG manufacturer. It also undertakes installation and O&M of all WTG sales. Operations include design development and manufacturing of all major components, including rotor blades, tubular towers, generators, control equipment, gears, and nacelles.

With a market capitalization of Rs 54,844 crore, the shares of this company closed at Rs 39.99 per share, down by 0.52% from its previous close. The global Vanguard fund holds a 2.2% stake in the company, which trades at an attractive P/E of 17x versus the industry average of 32.5x, while delivering strong profitability metrics with a 32.5% ROCE and 41.4% ROE.

Redington Ltd

Established in the year 1993, Redington Limited is a leading distributor of IT and mobility products and a provider of supply chain management solutions and support services in India, the Middle East, Turkey, and Africa. Its core business being Distribution of PCs, laptops, smartphones, wearables, printers, and enterprise software.

With a market capitalization of Rs 19,247 crore, the shares of this company closed at Rs 246.20 per share, down by 1.05% from its previous close. The global Vanguard fund holds a 2.1% stake in the company, which trades at an attractive P/E of 13.8x versus the industry average of32.1x, while delivering strong profitability metrics with a 18.9% ROCE and 14.4% ROE.

Cyient Ltd

Cyient is an Indian multinational technology company that is focused on engineering, manufacturing, data analytics, and networks and operations. Operates through two main paths: Cyient DET (Digital, Engineering & Technology) for, and Cyient DLM (Design, Lead, Manufacture) for electronic system manufacturing.

With a market capitalization of Rs 9,867 crore, the shares of this company closed at Rs 888 per share, up by 0.34% from its previous close. The global Vanguard fund holds a 2.1% stake in the company, which trades at an attractive P/E of 17.4x versus the industry average of 23.6x, while delivering strong profitability metrics with a 16.6% ROCE and 12.8% ROE.

Crompton Greaves Consumer Electricals Ltd

Crompton Greaves Consumer Electricals Limited is one of the leading consumer companies in India with a 75+ year-old brand legacy. It is an independent company under professional management and has 2 business segments – Lighting and Electrical Consumer Durables. We market our products under the “Crompton” brand name in India and select export markets

With a market capitalization of Rs XX crore, the shares of this company closed at Rs 248.20 per share, down by 0.64% from its previous close. The global Vanguard fund holds a 2.8% stake in the company, which trades at an attractive P/E of 32.3x versus the industry average of 44.3x, while delivering strong profitability metrics with a 19% ROCE and 17.4% ROE.

Cipla Ltd

Cipla Ltd is a leading Indian pharmaceutical company headquartered in Mumbai. It manufactures branded and generic medicines across segments such as respiratory, cardiology, oncology, and HIV treatment. With a strong presence in India, the US, and emerging markets, Cipla focuses on affordable healthcare, innovation, and steady long-term growth.

With a market capitalization of Rs 1,06,768 crore, the shares of this company closed at Rs 1,321 per share, down by 0.31% from its previous close. The global Vanguard fund holds a 1% stake in the company, which trades at an attractive P/E of 22.6x versus the industry average of 27.7x, while delivering strong profitability metrics with a 22.7% ROCE and 17.8% ROE.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post 5 Stocks Held by Vanguard with P/E Ratio Lower Than the Industry Average appeared first on Trade Brains.